Clinical Trial Update: A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis [Phase 3]

View source ↗

Summary

Phase 3 trial of SYM-1219 for bacterial vaginosis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• SYM-1219

Snippet

Sponsor: Symbiomix Therapeutics | Conditions: Bacterial Vaginosis | Phase 3 | Status: COMPLETED | Results posted: 2021-04-13